Sygnature Discovery partners with DaltonTx to enhance AI-driven drug discovery capabilities
Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery
Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery
Subscribe To Our Newsletter & Stay Updated